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CHAPTER I 
INTRODUCTION 
Conditioned taste aversion (CTA) is the learned avoid-· 
ance of a substance when its ingestion is followed one or 
more times by the administration of certain pharmacologi-
cal agents or physical treatments. The terminology of 
classical (or Pavlovian) conditioning designates the aver-
sive agent or treatment as the unconditioned stimulus (UCS). 
The conditioned stimulus (CS) is the substance (actually 
the taste of the substance) which is subsequently avoided. 
Though it is possible to use a CS with which the sub-
ject is familiar (Ahlers & Best, 1971; Jacquet, 1973), it 
is more common practice to expose the subject to a novel 
stimulus. Saccharin has been widely used as CS due to its 
distinctive taste and the ease with which subjects form 
associations to it. Although saccharin has little or no 
nutritional value, it is not a neutral stimulus. The 
highly rewarding properties of this substance are well 
documented (Sheffield & Roby, 1950~ Collier, 1962; Foster, 
1968; Colavita, 1968). Saccharin solution availability 
results in a marked increase in the fluid consumption of 
mice or rats once a subject's initial neophobia to a novel 
taste is overcome (Garcia, Hankins, & Rusiniak, 1974). 
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When rats are given simultaneous access to both tap water 
and saccharin solution, the consumption of saccharin so-
lution accounts for up to 90% of total fluid consumption 
in subjects which have not been conditioned to avoid sac-
charin (Martin & Ellinwood, 1973). Thus, the establish-
ment of a CTA to saccharin requires the learning of an 
aversion to a stimulus which would otherwise be rewarding. 
This property of the CS is important in establishing cri-
teria for the attainment of a CTA response. In what is 
referred to as a "single-bottle" test (only the CS solu-
tion is available for drinking), the consumption of sac-
charin after aversive conditioning is compared to the con-
sumption prior to conditioning, or to an unconditioned 
control subject's consumption on test day. Such a compar-
ison must acknowledge the changing baseline of consumption 
in control animals. Subject' s initial consumption (on 
treatment or "pairing" trials) will be attenuated by neo-
phobia for the novel solution. Subsequent consumption 
will rise with repeated presentations of the CS until 
the full reward potential of the CS is apparent (Garcia 
et al., 1966; Garcia & Ervin, 1968; Berman & Cannon, 
1974). 
An alternate test which avoids the problem of a 
changing baseline is the "two-bottle" choice test. In 
this paradigm the CS is again the only available solution 
during pairing with the UCS drug or treatment, but when 
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subsequent aversion is tested both the CS and tap water 
are available. From the record of the relative consump-
tion of the two solutions a "saccharin preference ratio" 
score is computed (saccharin preference ratio = [saccharin 
consumption in g or ml/total fluid consumption in g or 
ml] X 100}. A score of 100% indicates that only saccha-
rin was consumed, a score of 50% indicates equal consump-
tion of saccharin and water, and a score of 0% indicates 
that only water has been consumed. The saccharin prefer-
ence ratio of a treatment group may then be compared to 
the ratio of an untreated control group, which is usually 
about 90% (Martin & Ellinwood, 1973}. The two-bottle 
test is reportedly a more sensitive test for aversion 
(Grote & Brown, 1971}, but typically results in a some-
what higher heterogeneity of variance (Martin & Ellin-
wood, 1973). It has also been reported that preference 
scores in two-bottle tests are markedly influenced by 
prior experience with the CS (Goudie & Thornton, 1975), 
hence the one-bottle test may be more appropriate when 
many training sessions are used. The advantage of a 
two-bottle test is that because the subject's preference 
is measured, the overall motivation to drink cannot con-
found the results. 
Despite the common terminology, CTA differs from 
classical conditioning in several respects. First, a 
single cs-ucs pairing is effective for many drugs (Berger, 
1972; Carroll & Smith, 1974; Nachman & Hartley, 1975). 
Secondly, the time interval between presentation of the 
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CS and administration of the UCS may be much longer (sev-
eral hours) than would be effective in classical condi-
tioning (Garcia et al., 1966; Garcia & Ervin, 1968; Ber-
ger, 1972; Cappell & LeBlanc, 1975a). That such an ex-
tended cs-ucs interval should be effective is in direct 
violation of the "contiguity rule" of conditioning which 
specifies that punishing or rewarding stimuli must immedi-
ately follow signals, or responses, or both, if learning 
is to occur. Thirdly, the Pavlovian rule of the "equi-
potentiality of conditioned stimuli (CS) ," which holds 
that any perceptible stimulus can signal an animal that 
reward or punishment is eminent, is apparently also vi-
olated by CTA learning. A series of studies (Garcia et 
al., 1966; Garcia & Ervin, 1968, Garcia et al., 1974; 
Rozin, 1969) have shown that subjects acquire aversions 
only to the taste of the food or solution, not for the 
size or shape of the food, nor for the dish it is served 
in, nor for a clicking sound produced electronically by 
licking the drinking spout. The preferential a~sociation 
of taste with UCS effects has been termed the "belong-
ingness hypothesis." The same series of reports found 
that, if punished by electric shock, a rat will acquire 
an aversion to the clicking sound, but it is very diffi-
cult to establish a taste aversion to electric shock. 
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From these results Garcia et al. (1968, 1974) concluded 
that when animals suffer a ''general malaise" of the type 
presumably produced by CTA training they display avoid-
ance responses to chemical (gustatory or olfactory) 
stimuli but not to telereceptive (auditory, visual, or 
tactile) stimuli. When peripheral pain is the UCS, the 
converse is true. As supporting evidence for such a dual 
neural control system they noted that gustatory and vis-
ceral systems, including the area postrema, send afferent 
fibers directly to the nucleus of the fasciculus soli-
tarius. Telereceptive and cutaneous systems do not. 
Properties of the UCS Agents 
Since most of the original CTA studies used X-
irradiation, apomorphine, or lithium chloride as the UCS, 
it was first thought that the mechanism by which drugs or 
physical treatments induce CTA involved gastrointestinal 
distress. It now seems doubtful that such distress is 
necessary for establishment of a CTA response. 
Berger, Wise, and Stein (1973) investigated the ef-
fects of lesions in the area postrema on taste aversions. 
This site has been classified as an emetic chemoreceptor 
trigger zone and its ablation reduces drug-induced vomiting 
in cats (Borison & Wang, 1953). In rats, such lesions pre-
vented formation of a CTA based on methylscopolamine but 
not CTA based on amphetamine, indicating that the integrity 
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of the area postrema is not necessary for establishing CTA 
to amphetamine. In another study (Levy et al., 1974) pre-
treatment with an anti-emetic was ineffective in preventing 
CTA formation. In general, the evidence suggests that 
neither emesis, nausea, gastrointestinal malaise, nor "sick-
ness" in general are necessary to induce CTA (Berger, 1972; 
Gamzu, 1974; Cappell & LeBlanc, 1977; Vogel, 1976). In 
fact, "sickness" may not even be sufficient to induce CTA. 
Nachman and Bartley (1975) used UCS drugs and dosages which 
were chosen for their toxicity (doses of rodenticides suf-
ficient to produce behaviorally observable malaise). So-
dium fluoroacetate (1.6 mg/kg), copper sulfate (5.0 mg/kg), 
red squill (35.0 mg/kg), thallium sulfate (10.0 mg/kg), and 
lithium chloride (127.2 mg/kg; which is not a rodenticide) 
were effective UCS agents after only one pairing with sac-
charin. Yet doses of warfarin (12.5 mg/kg), cyanide (2.0 
mg/kg), and strychnine (1.0 mg/kg) which were 30 to 50% of 
the LD100 were insufficient to produce CTA; additionally, 
a near lethal dose of strychnine (2.0 mg/kg) was only mar-
ginally effective. A comparable study reports the failure 
of cyanide (4.0 mg/kg), pyrollopyrimidine (15.0 mg/kg), 
gallamine (40 mg/kg), and malonate (0.1 M; 1% body weight) 
to produce conditioned taste aversions (Ionescu & Buresova, 
1977). The investigators emphasized the poor correlation 
between the degree of observable malaise due to the drugs 
and their relative effectiveness in CTA production. Lithium 
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chloride produces only a mild diarrhea but is quite potent 
in CTA production. Strychnine, however, produced death by 
convulsion in several subjects without producing more than 
a marginal CTA to saccharin in survivors. 
The range of effective UCS drugs is extremely wide. 
Lithium chloride (Cannon et al., 1975), apomorphine (Gamzu, 
1975; Wise et al., 1976), amphetamine (Berger et al., 1973; 
Cappell & LeBlanc, 1971), fenfluramine (Goudie & Thornton, 
1975), scopolamine and methylscopolamine (Berger et al., 
1973), barbiturates (Vogel & Nathan, 1975), ethanol (Can-
non et al., 1975), morphine (Coussens et al., 1973; Parker, 
Failor, & Weidman, 1973; Cappell et al., 1975), diazepam 
(Gamzu, 1975), meprobamate (Gamzu, 1975), mescaline (Cap-
pell & LeBlanc, 1971), delta-9 tetrahydrocannabinol and 
hashish extracts (Ellsmore, 1972; Corcoran, 1973), and 
even glucose (Deutsch et al., 1976) are among the drugs 
reported effective as the UCS in the CTA paradigm. Physi-
cal treatments which are effective as the UCS include X-
irradiation (Garcia & Koelling, 1967) and rapid whole body 
rotation (Braveman, 1977). 
The only pharmacologically active compounds which 
have been reported as ineffective UCS drugs by more than 
one author are strychnine (Berger, 1972; Nachman & Hartley, 
1975; Vogel, 1976), cyanide (Nachman & Hartley, 1975; 
Ionescu & Buresova, 1976), and cocaine (Cappell & LeBlanc, 
1975b & 1977). It may yet prove that these "ineffective'' 
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drugs are capable of producing CTA when administered in 
high enough doses. It is now known that cocaine, for ex-
ample, must be administered at a dose of 10 to 36 mg/kg 
to obtain even a very weak CTA (Goudie et al., 1978), and 
that such a dose produces marked behavioral effects. How-
ever, the need for such high doses remains in contrast to 
most of the effective UCS drugs. Amphetamines.can induce 
CTA at a dose (0.1 mg/kg) which has minimal behavioral ef-
fects (D'Mello et al., 1977). Goudie et al. (1978) sug-
gest that the difference between these two compounds may 
be due to their different temporal profiles of action. 
Peak behavioral effects occur much sooner for cocaine 
(15 min.) as opposed to d-amphetamine (one hour). Cocaine 
also has a shorter duration of action. It is interesting 
that while cocaine is a weak aversive agent for CTA it 
is a very potent reinforcing agent in self-administration 
studies even at doses below 0.64 mg/kg i.v. (Thompson & 
Pickens, 1975). 
It is difficult to explain how such a wide variety of 
agents of different pharmacological classes could all be 
effective through a gastrointestinal (GI) mechanism since 
many have no well established GI side effects and a few 
of the effective UCS drugs are actually used to relieve 
certain types of GI distress (anticholinergics: atropine 
and scopolamine). The range of effective UCS drugs is 
also not explained by the general toxicity of high doses. 
A number of authors (Berger, 1972; Cappel et al., 1973; 
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Cappell & LeBlanc, 1977; Vogel, 1976) have produced CTA 
using psychopharmacological agents at doses which do not 
produce any signs of toxicity. Indeed, some drugs such 
as amphetamine (Pickens & Harris, 1968), morphine (Weeks, 
1962), and apomorphine (Baxter et al., 1974) are self-
administered by experimental animals at dosages which are 
effective in establishing CTA. 
It appears, in fact, that some agents can be aversive 
and rewarding at the same time. Wise et al. (1976) demon-
strated that subjects would lever-press for the very in-
jections that produced taste aversions. First it was 
demonstrated that rats with a history of d-amphetamine 
self-administration (1.0 mg/kg i.v.) could learn an aver-
sion for the same dose and vice versa. In a second exper-
iment animals were trained to lever press for amphetamine, 
then apomorphine (0.5 mg/kg i.v.) was substituted. The 
intent of the authors was to present the saccharin CS on 
the first day in which the reinforcing effect of the drug 
could be demonstrated. Previous work showed that when an-
imals having a history of amphetamine self-administration 
are switched to apomorphine, the rewarding properties of 
apomorphine are apparent on the first day of substitution. 
Immediately prior to the switch to apomorphine, the 
amphetamine-trained animals were presented with a novel 
saccharin solution. On the following day, those subjects 
whose rate of responding indicated stable apomorphine 
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self-administration were again given access to saccharin. 
These subjects showed an aversion relative to controls in 
a one-bottle test. Apomorphine self-administration ses-
sions were continued to verify that lever pressing was 
truly sustained by apomorphine rather than by the habit 
established under amphetamine. 
Physiological Manipulation of CTA 
Another possible explanation for the wide variety of 
effective agents would be that all the effective UCS drugs 
affect some common physiological system or act through a 
common biochemical substrate. The CNS would appear to be 
a likely candidate since many of the agents (chlordiaz-
epoxide, diazepam, barbiturates, amphetamines, and hallu-
cinogens) dohave CNS effects. Yet, some of the active 
drugs (methylscopolamine, methyl atropine, or copper sul-
fate, for example) do not readily penetrate the blood-
brain barrier. To hypothesize a common physiological sys-
tem or substrate one must explain how both drugs of an 
agonist-antagonist pair can be effective in producing CTA. 
Vogel (1976) produced CTA with both methyl atropine and 
eserine, which have opposite effects on cholinergic sys-
tems. Similarly, both chlorpromazine and apomorphine, 
which have opposite effects on dopaminergic systems, are 
effective inducers of CTA {Gamzu, 1977). Treatments that 
increase histamine levels are effective {Levy et al., 1974) 
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and so are drugs with some antihistaminic effects (chlor-
promazine: Berger, 1972). Finally, both morphine and 
its antagonist naloxone can be used to establish CTA (Le-
Blanc & Cappell, 1975). 
In view of the above findings it would seem that if 
there exists a single common aversion-inducing mechanism 
it is one which is relatively non-specific with respect 
to the UCS drugs and physical treatments employed. One 
hypothesis is that certain stress-related physiological 
changes which are produced by the various treatments form 
the generalized aversive property common to all the dif-
ferent UCS drugs and treatments (Fischer, 1978; Brave-
man, 1977). Noting that systemic histamine levels peak 
one to two hours after X-irradiation, Levy et al. (1974) 
demonstrated that pretreatment with an antihistamine could 
block the formation of radiation-induced CTA. Such pre-
treatment was ineffective, however, against CTA induced 
by lithium chloride, and was only partially effective in 
blocking the aversion induced by cyclophosphamide (Levy 
et al., 1974; Levy, 1975). 
Another line of research into the stress hypothesis 
is centered upon the pituitary-adrenal system. The evi-
dence suggests that adrenocorticotropic hormone (ACTH) 
from the anterior pituitary may facilitate the acquisi-
tion of passive avoidance behavior (Levine & Jones, 1965; 
Guth et al., 1971) while suppression of ACTH release 
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through the administration of exogenous corticosterone 
(resulting in decreased ACTH release due to negative feed-
back) interferes with avoidance behavior (Levine & Levin, 
1970; Bohus, 1973). These results were obtained in pas-
sive avoidance tasks in which an animal learns to avoid 
that portion of the cage in which electric shocks are de-
livered. Hennessy et al. (1976) extended these findings 
to the study of CTA. Injections of lithium chloride in a 
dose suitable for producing CTA (126 mg/kg) resulted in a 
sustained increase in plasma corticosterone levels. In 
the second part of their experiment, animals were pre-
treated with either 400 ~g of dexamethasone (a synthetic 
glucocorticoid), saline, or ACTH (8.0 IU) given access to 
a flavored solution, and then given a lithium chloride in-
jection. The results suggest the ACTH pretreated group 
established an aversion somewhat stronger than that of the 
saline pretreated controls, while the dexamethasone pre-
treated animals had a somewhat weaker CTA than did the 
controls. 
Results of a recent study (Ader et al., 1978) indi-
cate that the adrenal gland itself need not be intact for 
conditioning to be effective. Bilateral adrenalectomies 
were performed on 45 male rats and confirmed by post-
experiment determination of plasma corticosterone concen-
trations. Control subjects were sham-operated. Experi-
mental animals were maintained in a healthy state by 
13 
providing a 0.9% saline solution for drinking and by ad-
ministering daily injections of dexamethasone (2.0 ~g) in 
sesame oil. Control animals continued drinking tap water 
and were injected with sesame oil only. After recovery 
from sugery and adaptation to a restricted drinking sched-
ule the subjects were given access to saccharin (saccharin 
in saline for experimental animals) and then injected i.p. 
with 50 mg/kg cyclophosphamide. Control groups for both 
the adrenalectomized and sham-operated animals had the UCS 
drug paired with tap water or saline as the CS. Two days 
after this single cs-ucs pairing, subjects were tested for 
CTA formation using a single-bottle test. Adrenalecto-
mized animals had a significantly higher baseline intake 
of saccharin on pairing day {attenuated neophobia) but, 
taking this factor into account, did not differ from con-
trols in the volume of saccharin consumed on test days. 
The Pretreatment Effect 
Another line of evidence which suggests a relatively 
non-specific aversion-inducing mechanism(s) comes from 
studies of the effect of pre-exposure to the UCS drug or 
treatment prior to CTA conditioning. Subjects pretreated 
with the UCS drug show less aversion to the flavored solu-
tion {CS) after pairing with the UCS than do saline pre-
treated controls. In some cases they show no aversion at 
all (scores comparable to an untreated animal). The 
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pretreatment effect also has been demonstrated for a wide 
variety of drugs and treatments: ethanol (Berman & Cannon, 
1974; Cannon et al., 1975), amphetamine (Cappell & LeBlanc, 
1975a; Goudie & Thornton, 1975; Goudie et al., 1976), chlor-
diazepoxide (Cappell & LeBlanc, 1973}, barbiturates (Vogel 
& Nathan, 1976), apomorphine (Gamzu, 1975), morphine (Par-
ker et al., 1973; Jacquet, 1973; LeBlanc & Cappell, 1974), 
and lithium chloride (Cannon et al., 1975}. 
An early demonstration of the pre-exposure effect de-
veloped from an attempt to condition a taste preference to 
a CS. Such results had only been attained when a subject 
suffering thiamine deficiency was exposed to a novel taste 
(CS) followed by an injection of thiamine (UCS), or when 
the CS was presented as the subject recovered from apomor-
phine induced illness (Garcia et al., 1974). Parker et al. 
(1973) wished to determine if comparable results could be 
obtained by alleviating a need that does not occur in na-
ture and for which the species could not have evolved re-
pletion mechanisms. Morphine withdrawal, they reasoned, 
should produce such an ''artificial need state" in animals 
dependent on morphine, thus pairing morphine with the first 
presentation of the CS should produce a preference for the 
CS under these conditions. Rats were pretreated for 25 
days with a dose of morphine which began at 20 mg/kg and 
increased by 5 mg/kg daily until a final dose of 140 mg/kg 
was obtained. This was followed by a three day period in 
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which morphine was withheld. Initial preference for a 
sucrose-octa-acetate solution was established during this 
96 hour withdrawal period using a continuous two-bottle 
preference test (this procedure constituted a pre-
exposure to the CS before conditioning as well as UCS 
pre-exposure). Beginning on day 30, a three day cycle 
was instituted in which the taste of sucrose-acta-
acetate was paired with 95 mg/kg morphine, followed by 
two days of limited access to plain tap water with no 
drug injections. This three day cycle was repeated seven 
times (seven "pairings'' or conditioning trials) and then 
preference on a two-bottle test was measured over a 96 
hour period. Control groups included one which received 
the pretreatments but not the conditioning trials (mer-
phone paired with no liquid instead) and a second which 
received saline instead of morphine during pretreatments 
(non-dependent control) but had the morphine-taste pair-
ings. Prior to conditioning, both of the morphine pre-
treated groups were more aversive to the flavor than 
saline pretreated controls. This effect was observed 
daily during the 96 hour withdrawal period, indicating 
that withdrawal stress may be an effective UCS (may be 
associated with a novel taste). After conditioning the 
group which received both the morphine pretreatments and 
the CTA pairings showed an attenuated CTA relative to the 
two control groups, which did not differ. CTA in the 
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experimental group was attenuated with respect to precon-
ditioning level of aversion (preference shift) as well as 
in comparison to controls. Parker et al. (1973) concluded 
that the pretreatment effect (attenuation of CTA) was due 
to the conversion of the UCS to a positively reinforcing 
stimulus in subjects having an artificially induced need 
state. The identical preference of the two control groups 
appeared to be due to morphine withdrawal on the one hand 
and to morphine presentation (to a non-dependent animal) 
on the other. 
In a different paradigm Jacquet (1973) maintained 
mice on morphine (25-250 mg/kg escalating over 10 days, or 
constant doses in this range in other replications) or 
saline, and paired each with water or with saccharin 15 
times. Each trial was both a cs-ucs pairing and a one-
bottle test. Experimental subjects showed a progressive 
CTA to either solution over days. A behavioral test for 
dependence (compulsive jumping during withdrawal or after 
treatment with 25 mg/kg naloxone) indicated that the ani-
mals treated with morphine were dependent but did not 
have a conditioned preference or even an attenuated aver-
sion to the CS. When the combined pairing and test trials 
were'given at 5 days intervals at constant doses (to pro-
duce tolerance, but not dependence), the same results were 
obtained. Jacquet concluded that the aversion obtained 
was due to morphine pairing rather than morphine abstinence. 
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The degree of aversion was dependent on dose and number of 
pairings but was independent of injection environment. 
Morphine was again one of the UCS drugs used by Le-
Blanc and Cappell (1974) in investigating the pretreatment 
effect. Prior to restricting drinking schedules, rats 
were pretreated with: a) 20-200 mg/kg morphine escalating 
over 16 days, b) saline for 11 days followed by 20-40 mg/kg 
morphine, dosage escalated over 5 days, or c) saline for 
16 days. The UCS dose of morphine was 20 mg/kg and was 
paired with saccharin six times and each injection was 
given 42 hours after the last pretreatment or pairing dose. 
The two dependent groups received either the 20 rng/kg mor-
phine or saline as UCS and had supplemental doses of mor-
phine to maintain their dependence. The saline pretreated 
group was also divided and given additional saline injec-
tions. Morphine pretreatment in this manner was totally 
effective in blocking CTA. In the dependent groups condi-
tioned to saline an upward trend occurred in saccharin 
consumption even though saccharin was repeatedly paired 
with 41 hours of morphine withdrawal. This finding is in-
consistent with the Parker et al. (1973) study and LeBlanc 
and Cappell (1974) suggest the previous data may have re-
flected an unconditioned neophobia rather than an aversion 
based on withdrawal. LeBlanc and Cappell replicated their 
study using amphetamine (pretreatment schedule of 10-20 
mg/kg or 2-4 mg/kg escalated over 15 days; and 1.0 mg/kg 
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UCS dose on pairing days). Results were the same except 
that amphetamine abstinence did not have the tendency to 
disrupt fluid intake, whereas morphine abstinence did. 
LeBlanc and Cappell (1974) suggest that pretreatment in-
duces tolerance to morphine or amphetamine which renders 
the UCS drug less effective. They reject an explanation 
based on dependence and withdrawal since morphine and am-
phetamine differ greatly in ability to produce withdrawal 
symptoms (Kalant ·et al., 1971). 
To investigate the rate of acquisition and loss of 
the pretreatment effect, Cappell and LeBlanc (1975b) pre-
treated rats with a constant (7.5 mg/kg) dose of ampheta-
mine for a total of 0, 1, 5, or 20 days prior to CTA 
training with a 1.0 mg/kg dose of the drug. Results in-
dicated that 5 or more pretreatments were needed at this 
dose to attenuate CTA. The time lapse between the end of 
pretreatments and the beginning of CTA training was also 
investigated. Subjects were withdrawn from a 20 mg/kg 
pretreatment regimen of amphetamine for 1, 7, or 14 days 
prior to CTA conditioning. The UCS pairing dose of am-
phetamine was 1.0 mg/kg. The group which had received no 
pretreatments for 14 days prior to training did not have 
an attenuated aversion, indicating that pairing trials 
must follow pretreatments within seven days if the pre-
treatments are to be effective. Elkins (1974) also in-
vestigated the effect of number of pretreatments. Six 
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pretreatments with cyclophosphamide (12.5 mg/kg) attenu-
ated CTA induced by the same dose and incr~ased the rate 
of extinction of the aversion. Three pretreatments failed 
to attenuate CTA magnitude but did reduce resistance to 
extinction. One pretreatment had no effect. 
Another series of studies which manipulated many of 
the experimental parameters known to be involved in CTA 
was conducted by Cannon et al. (1975). When the UCS was 
400 mg/kg ethanol administered intragastrically, pretreat-
ment for five, three, or even only one day attenuated CTA 
development by the same dose and the effect was greatest 
for the greatest number of pretreatments. To investigate 
the role of tolerance a 0.02 ml/g body wt. dose of 0.12 M 
lithium chloride was chosen as UCS (delivered intragastri-
cally, as were all UCS and pretreatment drugs). Lithium 
chloride was chosen because it is not known to produce 
metabolic tolerance. Four groups received either a single 
lithium chloride pretreatment or a single saline injec-
tion, eight, four, or one day prior to conditioning. Con-
ditioning consisted of eight cs-ucs pairings using the 
same dose of LiCl or saline. These trials were also test 
days, since consumption was measured in a one-bottle test. 
The aversive animals showed a progressive decline in sac-
charin intake over the eight days. Only the group pre-
treated one day prior to the eight conditioning trials had 
an attenuated CTA. These results agree with Jacquet (1973) 
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concerning the effectiveness of a single pretreatment but 
are in contrast to Cappell and LeBlanc's (1975a) and El-
kins' (1974) data which indicated the necessity of at 
least three pretreatments. The demonstration of the pre-
treatment effect for lithium chloride led Cannon et al. 
(1975) to argue that while tolerance may well be a factor 
in the pretreatment effect it is not a necessary prerequi-
site for demonstrating the attenuation of CTA. 
In another part of this study (Cannon et al., 1975) 
the same dose of lithium chloride was paired with a novel 
flavor (Sustecal liquid diet) or with water. Twenty-four 
hours later, conditioning an aversion to saccharin was 
attempted. The group having UCS pretreatment paired with 
liquid diet was less aversive to saccharin than the group 
having UCS pretreatment paired with water. It appears 
that preceding a UCS pre-exposure with an explicit cue 
(liquid diet flavor) reduces the degree to which pretreat-
ment is effective in attenuating CTA to a differenttaste 
CS. This result is incompatible with the "novelty hypoth-
es.is," which holds that any two groups having prior exper-
ience with the UCS (reduced novelty of the UCS induced 
drug state) should have the same degree of attenuation of 
CTA tp that UCS (Gamzu, 1974, 1975, & 1977). Likewise, 
a group given pretreatments of the lithium chloride UCS, 
but no pairing to the CS, failed to develop a preference 
for saccharin over and above that of a group never given 
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the UCS. This result is incompatible with the hypothesis 
that the CS is associated with ucs withdrawal, as postu-
lated by Parker et al. (1973). 
·when Cannon et al. (1975) varied the dose of lithium 
chloride used in pretreatment and/or pairing (0.02 ml/g 
body wt. of 0.0, 0.12, or 0.36 M lithium chloride) they 
reported that each pretreated group had an attenuated CTA 
relative to the naive group paired with the same dose. 
When the pairing (conditioning) dose was held constant a 
greater pretreatment dose produced less aversion. When 
pretreatment dose was held constant a greater pairing dose 
produced greater aversion to saccharin. Finally, it was 
demonstrated that no difference in the level of CTA could 
be obtained by pretreating some groups in an environment 
different from others. This observation does not support 
the theory that subjects make associations to other pos-
sible stimuli in the injection environment which then corn-
pete with saccharin for the role of CS when aversions are 
being conditioned {association hypothesis). 
The Crossover Pretreatment Effect 
Tolerance and/or the reduction of drug novelty have 
often, been postulated as explanations for the pretreatment 
effect (Cappell et al., 1973 & 1975; Jacquet, 1973; Berman 
& Cannon, 1974; Garnzu, 1974, 1975, & 1977). Yet there re-
mains a line of evidence which these relatively simple 
concepts also have difficulty explaining. Pretreatment 
with one drug or procedure may attenuate CTA production 
by a totally different compound. This phenomenon has 
been termed the "crossover pretreatment effect." 
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An early demonstration of the crossover pretreatment 
effect employed morphine and amphetamine as UCS drugs 
(Cappel et al., 1975). Amphetamine pre-treatment (10-20 
mg/kg increased over 13 days) attenuated CTA production 
by both amphetamine (1.0 rng/kg) and morphine (6.0 mg/kg). 
However, morphine pretreatment {5-40 mg/kg, increased 
over 14 days) was not equally effective for both drugs. 
The morphine pretreatment attenuated CTA induced by mor-
phine (6.0 mg/kg) only, and was not effective in attenu-
ating CTA induced by amphetamine (1.0 mg/kg). 
Goudie and Thornton (1975) used constant doses of 
amphetamine (2.0 mg/kg) and fenfluramine (6.0 mg/kg) in 
a crossover pretreatment design. Fenfluramine was chosen 
because it does not produce dependence and is not self-
administered by rats. Subjects received nine pretreat-
ments of either amphetamine, fenfluramine, or saline, 
followed by a single pairing to one of the two drugs or 
to saline. The level of aversion was determined using a 
one-bottle test. Results showed that the doses used were 
sufficient to produce CTA when saline pretreatments were 
given. However, fenfluramine appeared to produce a some-
what stronger aversion than did amphetamine. Pretreatment 
with either drug attenuated CTA induced by the same 
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compound. In the crossover groups it was found that fen-
fluramine pretreatment attenuated CTA induced by amphet-
amine but not vice versa. Like the results of the Cappell 
et al. (1975) study, the results of this work indicated an 
asymmetry in the ability of the two drug pretreatments to 
attenuate CTA. 
Asymmetrical results were also obtained by Vogel and 
Nathan (1976) when three pretreatments of amobarbital (120 
mg/kg}, d-amphetamine (2.0 mg/kg) or saline preceded pair-
ing of saccharin to one of these three agents. The drug 
doses used produced equivalent levels of CTA when pretreat-
ments were with saline. Neither drug was capable of atten-
uating CTA produced by amphetamine at these doses. Amo-
barbital pretreatment did attenuate amobarbital-induced CTA 
however, and amphetamine pretreatment partially attenuated 
amobarbital-induced CTA as well. 
Gamzu (1977} reported that three pretreatments with 
2 mg/kg amphetamine attenuated CTA induced by the same dose 
of amphetamine, or CTA induced by a 15 mg/kg dose of chlor-
diazepoxide. Three pretreatments with 15 mg/kg chlordi-
azepoxide attenuated CTA to the same dose of chlordiazepox-
ide only, but had no effect on CTA induced by amphetamine 
(2.0 mg/kg}. 
Goudie et al. (1976) reported that pretreatment with 
d,l-methamphetamine (3.0 mg/kg) attenuated CTA produced by 
the same dose and that the extent of CTA was inversely 
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proportional to the number of pretreatments given. The 
effect reached an asymptote after nine pretreatments 
(further increases in the number of pretreatments did not 
increase the attenuation of CTA). When 14 pretreatments 
of the 3 mg/kg dose of methamphetamine were given, the 
attenuation of a 10 mg/kg pairing dose of methamphetamine 
was much less pronounced than that associated with the 
3 mg/kg pairing dose. The 14 pretreatments with metham-
phetamine (3.0 mg/kg) failed to attenuate CTA induced by 
fenfluramine (5.0 mg/kg), chloramphetamine (5.0 mg/kg) or 
morphine (20 mg/kg). These results indicated the impor-
tance of choice of pairing doses, pretreatment doses, and 
duration of pretreatment. The authors noted that it is 
difficult to state unequivocally that pretreatment with 
drug X fails to attenuate CTA induced by drug Y, since a 
different dose or number of pretreatments might prove 
effective. 
Cannon et al. (1977) compared the degree of attenua-
tion due to pretreatment with the same drug (pretreatment 
effect) with the attenuation due to pretreatment with a 
different drug (crossover pretreatment effect). Subjects 
were pretreated four times using a gastric intubation pro-
cedure. After a three day period in which no drugs were 
given, the animals were placed on a conditioning schedule 
in which cs-ucs pairing occurred every third day. A total 
of three cs-ucs pairings were used. The ucs drugs and 
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doses used were 500 mg/kg ethanol (37.5% v/v) and 0.02 
ml/g body wt. of 0.10 M lithium chloride. Pretreatments 
of ethanol, LiCl, or saline were matched with each of the 
agents in turn as the cs-ucs pairing drug. The ethanol 
and LiCl doses were equivalent in ability to produce CTA 
in saline pretreated controls. The attenuation of CTA due 
to pretreatment with the same drug used for pairing (pre-
treatment effect) was greater than the attenuation due to 
pretreatment with a different drug (crossover pretreatment 
effect). All pretreatments except saline were effective 
and the crossover pretreatment effects were symmetrical. 
A behavioral measure of tolerance (rotarod performance 
test) indicated a correlation between the level of CTA 
achieved and the degree of tolerance observed only for the 
groups pretreated with the same drug used for pairing. 
The authors conclude that some sort of general effects are 
operative in both types of pretreatment. When pretreat-
ment is with the same drug, additional drug-specific ef-
fects such as tolerance are also operative. 
Crossover effects between drug treatments and physi-
cal treatments have been reported by Braveman (1977). Five 
pretreatments of d-amphetamine (2.0 mg/kg), methylscopo-
lami~e (1.0 mg/kg), or a 10 mg/kg injection of 0.3 H LiCl 
all effectively reduced CTA induced by whole body rotation 
for 15 minutes at 60 rpm. This study has often been cited 
as evidence that the crossover effect is not tied to the 
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pharmacological nature of the drug treatments. This con-
clusion is compatible with the hypothesis of Cannon et al. 
(1977) that drug-specific effects are operative only when 
pretreatment drugs and pairing drugs are identical. 
The common finding that crossover effects are asym-
metrical may be due to parametric problems. The finding 
of Goudie and Thornton (1975) that fenfluramine pretreat-
ent attenuated CTA induced by amphetamine, but not vice 
versa, led these ·investigators to study the effect of dur-
ation of action of a drug. Fenflurarnine has a longer dur-
ation of action than amphetamine and appears to induce a 
stronger CTA in the absence of drug pretreatments. Thus, 
when fenfluramine was the pairing drug, it may have been 
more difficult to demonstrate a pretreatment effect since 
the degree of aversion was stronger to begin with. Goudie 
and Thornton (1977) tested the effect of prolonging the 
duration of action of amphetamine by inhibition of drug 
metabolism with SKF 525A. Rats were injected with saline 
or SKF 525A (10 mg/kg) two hours before the pairing of 
saccharin with saline or a 0.5 mg/kg dose of amphetamine. 
When saline was the UCS pairing agent the saline pretreated 
and SKF pretreated groups did not differ, indicating that 
pretreatment per se did not affect fluid intake. lihen am-
phetamine was the pairing drug the saline pretreated group 
displayed a typical aversion, while the SKF pretreated 
group displayed an even greater aversion. Apparently the 
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aversive properties of amphetantine were potentiated by the 
SKF pretreatment, presumably through prolonging the dura-
tion of action of amphetamine. 
Goudie and Dickins (1978) again demonstrated the im-
portance of duration of action, dose, and number of pair-
ing trials in a study using nitrous oxide as the UCS drug. 
The use of a gaseous agent allowed control of duration of 
action simply by terminating administration. Since ni-
trous oxide is relatively insoluble in plasma and all body 
compartments, including fat, and is not metabolized, it 
equilibrates rapidly with brain tissue. Apart from this 
brief period of equilibration, the duration of action is 
essentially equal to the duration of inhalation. Follow-
ing four pairing sessions in which 30 min. of N20 inhala-
tion followed saccharin drinking, the degree of CTA was 
directly proportional to the concentration of N2 0 used. A 
group receiving an 80% N2 0 concentration drank less after 
conditioning than one receiving a 60% N2 0 concentration, 
which, in turn, showed a CTA compared to controls receiv-
ing pure oxygen. When concentration was held constant and 
subjects were exposed to N2o for 0.5, 1.0, or 4.0 hours 
the level of CTA obtained was greater when the duration of 
expos.ure to the drug was longer. 
Many of the experimental parameters which are criti-
cal in the conditioning of taste aversions have now been 
elucidated. Among these are the number and dose of 
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pretreatments and cs-ucs pairings, the choice of drugs for 
conditioning or pretreatments, the duration of action of 
these drugs at the particular doses, and the time inter-
vals between pretreatment and conditioning and between pre-
sentation of the CS and the UCS. Because various research-
ers have manipulated different experimental parameters it 
is difficult to assess the extent to which the magnitude 
of the pretreatment effect depends on the specific drugs 
used. Part of the problem in this area has been the diffi-
culty in choosing doses of different compounds which will 
produce an equivalent level of CTA. Dose-response relation-
ships have not been thoroughly worked out for CTA in gen-
eral, and are particularly scarce with respect to the pre-
treatment effect (Gamzu, 1974 & 1975; Goudie et al., 1976). 
One of the objectives of this study was to determine 
the dose-response relationship for the pretreatment ef-
fect when pretreatment and training drug and dose were 
the same. The UCS drugs used in these studies were THC, 
amphetamine, diazepam, and morphine. The effect of three 
pretreatments on the establishment of a CTA response was 
determined for a given range of doses for each of these 
drugs. In addition, this report also presents the results 
of a _cro~sover pretreatment study in which three drugs of 
different pharmacological class were employed. Ampheta-
mine, diazepam, and THC each were tested as a pretreatment 
drug, with each agent in turn serving as the UCS training 
drug. The design of this series of experiments was the 
same as that used in the dose-response studies except 
that only one particular dose of each drug was used. 
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CHAPTER II 
MATERIALS AND METHODS 
General 
Subjects were naive male mice of the Swiss-Webster 
strain. Upon receipt the mice were allocated to home cages 
in the animal care facility (six mice per cage). They were 
allowed ad libitum access to food (Purina rat chow) and tap 
water for not less than one week after arrival. Lighting 
in this room was controlled automaticallyi the lights com-
ing on at 7:00 a.m. and shutting off at 9:00 p.m. each day. 
At the beginning of an experiment the mice ranged from 15 
to 25 g in weight. All mice used in an experiment were of 
the same age (three to six weeks, depending upon the experi-
ment). Groups within an experiment did not differ with re-
spect to mean weight or age. 
Throughout most of the two week duration of an experi-
ment the mice were restricted to a one-half hour drinking 
period in the morning. For this purpose the subjects were 
placed i~ individual 13 X 19 X 30 em plexiglass cages cov-
ered on top by a metal grid. Solutions available for drink-
ing (0.1% saccharin or tap water) were contained in 50 ml 
Erlenmeyer flasks fitted with a number two rubber stopper 
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with drinking spout. Fluid consumption was determined 
daily by weighing the bottles before and after the drink-
ing session. Fluid loss due to dripping was minimized by 
maintaining the bottles near full volume. The bottles 
were filled with fresh solution at least every second day. 
An empty drinking spout with stopper was inserted through 
the bars of the cage adjacent to the spout which delivered 
fluid. Food was available ad libitum in both the home 
cages and drinking cages throughout an experiment. 
An attempt was made to prevent the formation of con-
ditioned position preferences by alternating the side of 
the cage in which the solutions were placed. Table I 
specifies the solution(s) available and the side on which 
they were placed on a daily basis. With the exception of 
the two test days (in which both solutions were available), 
the empty drinking spout occupied the remaining position. 
The position of the drinking bottle (right or left) was 
the same for all cages each day except for the two CTA 
training days. On these two days, half of the drinking 
bottles were on one side of the cage and half on the other. 
Pretreatments were given in the home cage area on 
three consecutive afternoons. These injections were given 
four-to five hours after the last groups finished drinking. 
Since the first groups finished drinking several hours 
earlier, the time between drinking and pretreatments ranged 
from four to seven hours for different groups. The drug 
TABLE I 
EXPE.RIMENTAL PARADIGM FOR CTA STUDIES 
Day 
1 Water removed from home cage in morning. 
2 One-half hour access to water on right side in 
morning. 
3 (Pretreatment #1) : One-half hour access to water 
on left side in morning; drug injections in after-
noon. 
4 (Pretreatment #2): One-half hour access to water 
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on right side in morning; drug injections in after-
noon. 
5 (Pretreatment #3): One-half hour access to water 
on left side in morning; drug injections in after-
noon. 
6 One-half hour access to water on right side in 
morning; ad libitum access to water in home cage 
in afternoon. 
7 Ad libitum access to water in home cage. 
8 Water removed from home cage in morning. 
9 (CTA Training Day #1): One-half hour access to 
saccharin in morning followed immediately by i.p. 
drug injection. The saccharin bottle is on the 
right for one-half of each group and on the left 
for the other half. 
lD (CTA Training Day #2): Procedure as on day 9, ex-
cept the saccharin is placed on the side opposite 
the previous day. 
11 {Recovery): One-half hour access to water on left 
side in morning. 
12 (Recovery): One-half hour access to water on 
right side in morning~ 
13 {Two-Bottle Choice Test #1): One-half hour access 
to saccharin and water in morning; saccharin is on 
right side and water is on left side. 
14 (Two-Bottle Choice Test #2): One-half hour access 
to saccharin and water in morning; saccharin is 
on left side and water is on right side. 
------
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pretreatments were followed by a period of ad libitum ac-
cess to water in an effort to regain possible weight loss 
due to drug effects and water deprivation. 
Dose-Response Relationships for 
the Pretreatment Effect 
Ten groups of six mice each were used in these stud-
ies. Four doses of each UCS drug were used. Four groups 
received both the drug pretreatments and the conditioning 
injections and these were labeled DDl, DD2, DD3, and DD4 
(in order of increasing dosage). Another four groups re-
ceived pretreatments of the drug vehicle alone, followed 
by conditioning injections. These were labeled VDl, VD2, 
VD3, and VD4. One control group received vehicle injec-
tions both for pretreatment and CTA training (VV) , and 
another received the drug pretreatments but was injected 
with drug vehicle on CTA training days (DV). The dose of 
the drug given to group DV was the same as the highest 
used in any other group (DD4 and VD4). All injections 
were given i.p. at a constant volume of 10 ml/kg. 
Delta-9 Tetrahydrocannabinol 
· The paradigm used in this dose-response study differed 
from that described in Table I. On the first two days of 
this study five groups (six mice each) received drug pre-
treatments of 1.0, 5.0, 10, 20, or 40 mg/kg Delta-9 THC 
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dissolved in 2% Pluronic F-68 in 0.9% saline prepared as 
described by Sprague and Craigmill (1976). No drug vehicle 
pretreatments were given. At the time of pretreatments the 
animals were not water deprived. Ad libitum access to 
water was continued until-the fourth day, then the water 
was removed. The fifth day was the single CTA training 
day. After 30 minutes access to saccharin on the right 
side of the cage the subjects were injected with 1.0, 5.0, 
10, 20, or 40 mg/~g Delta-9 THC. Each group received the 
same dose which had been used for pretreatments. On the 
following two days (days 6 and 7), the mice were given 30 
minutes access to water. The water bottle was on the left 
side on day six and on the right side on day seven. An 
empty spigot occupied the adjacent position on both days. 
Saccharin preference was tested in a 30 minute drinking 
session on days eight and nine. On day eight the saccharin 
bottles occupied the right side of the cage for half of 
each group and were placed on the left side of the cage for 
the other half. Water bottles were placed in the remain-
ing position for each group. On day nine the positions of 
all bottles were switched and subjects were again given 
access to both solutions for 30 minutes. 
Diazepam 
Drug doses of diazepam were 0.625, 1.25, 2.50, and 
5.00 mg/kg. The stock solution (5 mg/ml) came dissolved 
in 10% propylene glycol and 2.5% ethanol. This solution 
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was diluted with vehicle to concentrations of 0.0625, 0.125, 
0.25, and 0.50 mg/ml. The drug vehicle was a solution of 
10% propylene glycol and 2.5% ethanol in physiological 
saline (0.9%). The volume of all injections was 10 ml/kg. 
D-Amphetamine 
Two independent experiments were used to cover the 
range of doses reported here. The first study used doses 
of 1.0, 2.0, 4.0, and 8.0 mg/kg d-amphetamine. Group DV 
received 8.0 mg/kg pretreatments in this study. Doses of 
0.25, 0.50, 0.75, and 1.00 mg/kg d-amphetamine were used 
in the second experiment. Group DV received 1.00 mg/kg 
pretreatments in the second study. A 0.9% saline solution 
was used for vehicle injections and for dilution of the 
stock (0.8 mg/ml) solution such that the volume of all drug 
injections was 10 ml/kg. 
Group DV of the first (higher doses) study was inad-
vertently given water prior to drinking on the second test 
day (day 14 of Table I). For this reason group DV re-
ceived the second two-bottle choice test one day late. 
A modification of the paradigm described in Table I 
was also necessary during the course of the second (lower 
doses) experiment. The room in which the mice normally 
were allowed the 30 minute drinking sessions was not avail-
able for two days. All groups were given fluid access in 
a new environment on the second CTA training day and the 
following recovery day (days 10 and 11 of Table I). 
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Morphine 
Drug doses used were 3.5, 6.9, 34.6, and 69.1 mg/kg 
morphine sulfate. Drug vehicle injections were of a 0.9% 
saline solution. The saline vehicle was also used to 
dilute the stock (0.691 mg/ml) solution to the various 
concentrations desired. All injections were given i.p. in 
a volume of 10 ml/kg. 
Demonstration of the Crossover 
Pretreatment Effect 
Twelve groups of five mice each were used in this 
series of studies. Three UCS drugs of widely different 
pharmacological class were used in an attempt to demonstrate 
the crospover pretreatment effect. Diazepam (DZP) was used 
at a constant dose (2.5 mg/kg) for both pretreatments and 
CTA training injections. The drug vehicle for diazepam 
was a solution of 10% propylene glycol and 2.5% ethanol in 
physiological saline (0.9%). Delta-9 tetrahydrocannabinol 
(THC) was also used at a constant dose (4.0 mg/kg) for all 
injections. The drug vehicle for THC was a solution of 2% 
Pluronic F-68 in 0.9% saline as described by Sprague and 
Craigmill (1976). D-amphetamine (AMPH) was the third UCS 
drug used and was also employed at a constant dose (4.0 
mg/kg) for all injections. The drug vehicle for d-
amphetamine was a 0.9% saline solution. All drug and ve-
hicle injections were given i.p. in a volume of 10 ml/kg. 
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Groups were labeled according to the pretreatment drug 
or vehicle used and the CTA training drug used. Thus, 
group AMPH/DZP received d-amphetamine pretreatments prior 
to CTA training with diazepam. Six groups (AMPH/DZP, THC/ 
DZP, AMPH/THC, DZP/THC, DZP/AMPH, and THC/k~PH) were in-
cluded in the first experiment. A second experiment in-
cluded groups THC/THC, AMPH/AMPH, and DZP/DZP; and a third 
experiment included the control groups VEH/THC, VEH/DZP, 
and VEH/AMPH (VEH stood for drug vehicle and depended upon 
the CTA training drug with which it was matched). 
Procedures for this series of studies differed some-
what from those described in Table I. The mice were housed 
in large (16 X 40 X 33 em) plexiglass cages covered by a 
metal framework. Five mice were kept in each cage. The 
drinking cages were the same as described previously. 
Drinking was monitored in the experimenter's lab area dur-
ing the first two experiments but occurred in a different 
room during the third experiment. A full hour of fluid 
access was allowed on day two of each experiment instead 
of the 30 minutes specified in Table I. During the third 
(control} experiment all subjects received saccharin on 
the same side of the cage on CTA training days. Saccharin 
bottles were on the left for all cages on day 9 and on the 
right on day 10 (see Table I). 
Statistical Analysis 
In all experiments the saccharin preference ratio 
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(SPR) scores were averaged over the two test days to ob-
tain a single score for each subject. These derived scores 
were then averaged to obtain a mean SPR score and standard 
deviation for each group. 
Student's one-tailed t test for unpaired observations 
was the principal test criterion throughout the dose-
response experiments. The level of significance for all 
t tests (one and two-tailed) was set at p ~ 0.05. Excep-
tions to this procedure were made for comparisons between 
experiments and for the treatment of group DV. A compari-
son of scores for group VV across all experiments and for 
group DV between the two experiments dealing with d-
amphetamine employed a two-tailed t test. Within each ex-
periment, group DV was compared to group VV using a two-
tailed t test and was compared to group DD4 using a one-
tailed t test (H0 : DV-DD4=0; HA: DV-DD4 > 0). Comparisons 
among the means of other groups fell into three categories. 
Each drug pretreated group was compared to the correspond-
ing vehicle pretreated group of the same dose to test for 
the pretreatment effect. All groups other than DV were 
compared to group VV using a one-tailed t test. Finally, 
a one-tailed t test was used for comparisons among groups 
which received the same treatment regimen but differed in 
dose. These tests were conducted with the expectation 
that the group which received the lowest dose would obtain 
the highest SPR. 
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Student's two-tailed t test for unpaired observations 
was used for comparisons among experimental groups in the 
crossover pretreatment experiments. However, each experi-
mental group was compared to the corresponding vehicle 
pretreated control group using a one-tailed t test. The 
level of significance for all t tests (one and two-tailed) 
was set at p ~ 0.05. Comparisons among groups were made 
as if all had been included in a single experiment. 
CHAPTER III 
RESULTS 
Dose-Response Relationships for 
the Pretreatment Effect 
Delta-9 Tetrahydrocannabinol 
Figure 1 shows the mean saccharin preference ratio 
(SPR) and standard deviation for each dose group. Groups 
DD3 (10 mg/kg) , DD4 (20 mg/kg) , and DDS (40 mg/kg) each 
had a significantly lower SPR than group DDl (1.0 mg/kg). 
In addition, groups DD3 (10 mg/kg) and DD4 (20 mg/kg) each 
had a significantly lower SPR than group DD2 (5.0 mg/kg). 
Diazepam 
Figure 2 presents the mean SPR for each group. Table 
III (see Appendix) lists the mean SPR and standard devia-
tion for each group. Group DD3 (2.5 mg/kg) had a signifi-
cantly higher SPR than did group VD3 (2.5 mg/kg). Groups 
DOl {0.625 mg/kg), VD2 (1.25 mg/kg}, VD3 (2.5 mg/kg), and 
VD4 (5.0 mg/kg) each had a lower SPR than group VV. Groups 
VD2 (1.25 mg/kg), VD3 (2.5 mg/kg), and VD4 (5.0 mg/kg) also 
had a lower SPR than group VDl (0.625 mg/kg). Group DV 
(5.0 mg/kg) did not differ from group VV or from group DD4 
(5.0 mg/kg). 
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Figure 1. Dose-Response Relationship for Delta-9 THC. 
Two pretreatments and one training injec-
tion of the drug were given to each group 
of six male mice. (a) indicates a signif-
icant difference between group DDl and 
any other group (p < 0.05). (b) indicates 
a significant difference between group 
DD2 and any other group (p < 0.05). 
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Figure 2. Dose-Response Relationship for Diazepam. 
Three pretreatments and two training in-
jections of the drug or its vehicle were 
given to each group of six male mice. 
Drug pretreated groups are designated by 
open points and vehicle pretreated groups 
by solid points. (a) indicates a signif-
icant difference between DD and VD groups 
(p < 0. 05). (b) indicates a significant 
difference between group VV and any other 
group (p < 0.05). 
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D-Amphetamine 
Figure 3 presents the mean SPR scores graphically and 
Table IV (see Appendix) lists the mean SPR and standard 
deviations for each group in these two experiments. Three 
groups were represented in both experiments. This repli-
cation allowed a comparison of scores for these groups be-
tween the two studies. Group VV of experiment one (high 
doses) did not differ from group VV of experiment two (low 
doses) when tested with a two-tailed Student's t test. 
Likewise, group DDl of experiment one (1.0 mg/kg) did not 
differ from group DD4 of experiment two (1.0 mg/kg). Fi-
nally, group VDl of experiment one (1.0 mg/kg) did not dif-
fer from group VD4 of experiment two (1.0 mg/kg). 
In experiment one (high doses), group DD3 (4.0 ~g/kg) 
had a significantly higher SPR than group VD3 (4.0 mg/kg). 
All groups except DDl (1.0 mg/kg) and DV (8.0 mg/kg) had 
a significantly lower SPR than group vv. Within treatment 
conditions, group DD4 (8.0 mg/kg) had a lower SPR than 
groups DDl (1.0 mg/kg), DD2 (2.0 mg/kg}, or DD3 (4.0 mg/kg) 
and group VD3 (4.0 mg/kg} had a lower SPR than group VDl 
(1.0 mg/kg). Group DV (8.0 mg/kg) did not differ from 
group VV but had a significantly higher SPR than group 
DD4 (8.0 mg/kg). 
In experiment two (low doses), group DDl (0.25 mg/kg) 
had a significantly higher SPR than group VDl (0.25 mg/kg). 
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Figure 3. Dose-Response Relationship for D-Arnphetamine. Three 
pretreatments and two training injections of the 
drug or its vehicle were given to each group of six 
male mice. Drug pretreated groups are designated by 
open points and vehicle pretreated groups by solid 
points. (a) indicates a significant difference be-
tween DD and VD groups (p < 0.05). (b) indicates a 
significant difference between group W and any other 
group (p < 0.05). Control groups DV and VV are 
marked with circles for the lower doses and squares 
for the higher doses. 
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Group VV did not differ from any other group. Within 
treatment conditions, groups DD2 (0.50 mg/kg) and DD3 
(0.75 mg/kg) had a lower SPR than group DDl (0.25 mg/kg). 
Group DV (1.0 mg/kg) did not differ from group VV or group 
DD4 (1.0 mg/kg). 
Morphine 
Figure 4 presents the mean SPR for each group. 
Table V (see Appendix) lists the mean SPR and standard de-
viation for each group. Group DD4 (69.1 mg/kg) had a 
higher SPR than group VD4 (69.1 mg/kg). Groups VD3 
.(34.6 mg/kg), VD4 (69.1 mg/kg), DD2 (6.91 mg/kg), DD3 
(34.6 mg/kg), and DD4 (69.1 mg/kg) each had a lower SPR 
than group VV. Within treatment conditions, groups VD3 
(34.6 mg/kg) and VD4 (69.1 mg/kg) each had a lower SPR 
than both group VDl (3.46 mg/kg) and group VD2 (6.91 mg/kg). 
Group DV (69.1 mg/kg) did not differ from group VV but had 
a higher SPR than group DD4 (69.1 mg/kg). 
A two-tailed t test was used to compare mean SPR 
scores for group VV between each of the four experiments 
which included this group (diazepam, amphetamine, and mor-
phine). No differences were found in the SPR of group VV 
between any of the experiments. 
Demonstration of the Crossover 
Pretreatment Effect 
Table II presents the mean SPR and standard deviation 
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Figure 4. Dose-Response Relationship for Morphine. 
Three pretreatments and two training 
· injections of the drug or its vehicle 
were given to each group of six male 
mice. Drug pretreated groups are des-
ignated by open points and vehicle pre-
treated groups by solid points. (a) in-
dicates a significant difference between 
DD and VD groups (p < 0. 05). (b) indi-
cates a significant difference between 
group VV and any other group (p < 0.05). 
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TABLE II 
MEAN SACCHARIN PREFERENCE RATIOS IN CROSS-
OVER PRETREATMENT EXPERIMENTS 
Pretreatment Drug CTA Training Drug 
Diazepam Amphetamine Delta-9 THC 
(2. 5 mg/kg) (4. 0 mg/kg) (4. 0 mg/kg) 
Diazepam *0.784 + 0.092 0.313 + 0.153 *0.740 + 0.103 
- - -(2. 5 mg/kg) 
Amphetamine *0.681 + 0.097 *0.601 + 0.153 0.713 + 0.117 
- -(4.0 mg/kg) 
Delta-9 THC 0.252 + 0.172 0.370 + 0.210 0.749 + 0.244 
- - -(4.0 mg/kg) 
Vehicle **0.300 + 0.246 0.167 + 0.205 0.478 + 0.277 
- -
*Significant pretreatment effect. 
**N=4 for this group; N=5 for all other groups. 
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for each group. When all the pretreatments were of the 
appropriate vehicle there were no differences between any 
of the three vehicle pretreated groups. Groups DZP/DZP 
and AMPH/DZP both had a significantly higher SPR than 
group VEH/DZP. Group AMPH/AMPH had a higher SPR than 
group VEH/AMPH. Finally, group DZP/THC had a significantly 
higher SPR than group VEH/THC. 
No combination of different pretreatment and training 
drugs showed symmetrical crossover. Group AMPH/DZP had a 
significantly higher SPR than group DZP/AMPH. Group DZP/ 
THC had a significantly higher SPR than group THC/DZP. 
Group AMPH/THC had a significantly higher SPR than group 
THC/AMPH. 
When the CTA training drug was diazepam, groups 
DZP/DZP and AMPH/DZP both had a significantly higher SPR 
than group THC/DZP. When the CTA training drug was d-
amphetamine, group AMPH/AMPH had a significantly higher 
SPR than group DZP/AMPH. When THC was the CTA training 
drug, no two drug pretreated groups differed from each 
other. 
When the pretreatment drug was diazepam, groups DZP/ 
DZP and DZP/THC each had a significantly higher SPR than 
group DZP/AMPH. When the pretreatment drug was d-
amphetamine, no difference was found among the three CTA 
training drugs. When the pretreatment drug was THC, groups 
THC/DZP and THC/AMPH each had a significantly lower SPR 
than group THC/THC. 
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A two-tailed t test was used to compare certain groups 
of this experiment to groups in the dose-response experi-
ments which received the same treatment. Group VEH/DZP 
(2.5 mg/kg) did not differ from group VD3 (2.5 mg/kg) of 
the diazepam dose-response experiment and group DZP/DZP 
did not differ from group DD3 (2.5 mg/kg) of the diazepam 
dose-response experiment. Likewise, group VEH/AMPH (4.0 
mg/kg) did not differ from group VD 3 (high dose, 4.0 
mg/kg) of the amphetamine dose-response experiment and 
group AMPH/AMPH did not differ from group DD3 (high dose, 
4.0 mg/kg) of the amphetamine dose-response experiment. 
CHAPTER IV 
DISCUSSION 
Choice of Paradigm 
When a two-bottle choice test is used to determine 
taste preference it is necessary to control for the pos-
sibility that a subject may form a position preference. 
In such a case an animal prefers to drink from a spout 
located in a particular part of the cage, regardless of 
the fluid available through this spout (Myers & Veale, 
1972). The alternation of sides on which the fluid filled 
bottle was placed (Table I) was designed to prevent the 
formation of such position preferences. The use of two 
CTA.training days allowed the mice to taste saccharin 
once on each side of the cage as well as having the ef-
fect of strengthening conditioning. Two recovery days 
followed the CTA training trials. Thus, the last CTA 
training day and the first two-bottle choice test day 
were separated by a 36 hour interval which was felt to be 
sufficient for most drug effects to wear off prior to the 
first preference test. The two-bottle preference test 
was conducted twice so that position preferences (indi-
cated by a large change in saccharin preference ratio) 
could be checked. Because no drug injections followed 
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saccharin drinking on test days, these may actually be con-
sidered extinction trials. Saccharin preference scores on 
test day #2 could be influenced by extinction learning on 
test day #1. 
A rigorous statistical test for position preferences 
would require an analysis of variance in which the two 
test days represent repeated sampling of an experimental 
unit. Such a procedure rarely finds position preferences 
(subsample number) to be a significant factor in the de-
termination of scores when bottle positions have been al-
ternated as described (Fischer, 1978). In lieu of such 
an analysis the author simply recorded the difference in 
scores between the two test days for individual subjects. 
A change in saccharin preference ratio of 0.5 or above 
was arbitrarily considered large enough to suspect a posi-
tion preference. Over all experiments only 5% of subjects 
had a shift in preference ratio of 0.5 or more. 
For the purpose of graphical representation and the 
calculation of group scores, an individual's preference 
ratio score was averaged over both test days. This pro-
cedure yielded a value of n which was equivalent to the 
number of subjects X number of test days. Such a proce-
dure also obscures the effect of position preferences in 
the rare individual which may exhibit this behavior, since 
a high score on test day #1 and. a low score on test day 
#2 yields an overall score near 0.5, which indicates equal 
preference for both solutions. 
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Although one pretreatment is often sufficient to at-
tenuate CTA formation (Cannon et al., 1975}, the degree 
of attenuation appears to be proportional to the number 
of pretreatments given (Goudie et al., 1976}. Previous 
work indicated that three to five pretreatments are ef-
fective with a wide variety of UCS drugs and experimental 
paradigms (see Chapter I}. Three pretreatment~ were chosen 
as the minimum number which might be effective with various 
drugs and doses without producing high mortality in the 
higher dose groups. Cappell and LeBlanc (1975a) indicate 
that cs-ucs pairing must follow pretreatments within seven 
days in the paradigm they employed. Yet, if the CTA train-
ing followed too closely after the pretreatments the sub-
jects might be learning under the influence of the drugs. 
The interval of 3.5 days between pretreatments and CTA 
training was thought to be long enough for drug effects to 
wear off and weight to be regained, without jeopardizing 
the effectiveness of the pretreatments. 
Pretreatments were given well after the drinking ses-
sions and in the home cage area, but CTA training injec-
tions were given immediately after drinking and in the 
drinking cage area. The "association hypothesis" for CTA 
claims that subjects may form aversions to handling, the 
injection procedure, or other stimuli in the environment 
{Gamzu, 1977}. The inability of many potential stimuli 
to act as the CS in CTA training has been discussed in 
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Chapter I. Though the issue of the 11 equipotentiality of 
conditioned stimuli 11 is not yet fully resolved, there is 
much evidence that at least the area in which injections 
are given does not affect the acquisition or attenuation 
of aCTA response (Jacquet, 1973; Cannon et al., 1975). 
Even when subjects were pretreated in quite different en-
vironments (some groups placed in cages rubbed with oil 
of cloves immediately before and after injections) the 
degree of attenuation achieved through pretreatment did 
not differ (Stewart & Eikelboom, 1978). 
Dose-Response Relationships for 
the Pretreatment Effect 
Delta-9 Tetrahvdrocannabinol 
This experiment was a pilot study and was conducted 
before the paradigm described in Table I was settled upon. 
This difference in the paradigm and the absence of con-
trol groups VDl-4, VV, and DV limit the extent to which 
these results can be compared to results for other UCS 
drugs. The conclusion from this experiment is that for 
~-9 THC the saccharin preference ratio scores of pretreated 
animals decrease with increasing dose. Without the ve-
hicle pretreated controls it is not possible to make any 
statements about how the degree of attenuation of CTA may 
vary with increasing dose. Most dose-response studies of 
CTA in drug naive (not pretreated) animals have shown these 
11111\11 
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preference ratio scores also decrease with increasing dose. 
This trend has been observed for non-pretreated animals 
when delta-9 THC is the UCS drug (Craigmill, 1978). The 
data indicates that such subjects have preference ratio 
scores below 0.5 at the doses used here. Curves for both 
the pretreated and drug naive animals thus show the same 
pattern of decreasing scores with increasing dose. It is 
not known whether these two curves would maintain a con-
stant distance between each other. Figure l suggests that 
the scores of pretreated animals are roughly constant at 
doses below 5.0 mg/kg or above 40 mg/kg. If the curve for 
drug naive animals showed the same inflection points (main-
taining a constant distance between the curves) this would 
indicate that the magnitude of attenuation of CTA due to 
pretreatment is independent of dose of THC. Further re-
search with this drug should include both drug pretreated 
and vehicle pretreated animals in the same experiment and 
should inlcude doses above 40 mg/kg. 
Diazepam 
The pretreatment effect was demonstrated only for the 
2.50 mg/kg dose of diazepam (groups DD3 vs. VD3). CTA 
training in vehicle pretreated groups produced an aversion 
at doses of 1.25, 2.50, and 5.00 mg/kg as reflected in the 
difference between these groups and group VV. An examina-
tion of the actual scores for these groups reveals that the 
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aversion was a mild one since preference scores were not 
far below the 0.5 (equal preference) mark. The pretreat-
ment effect would be harder to demonstrate at doses which 
produce only mild aversions and this factor may account 
for the finding that pretreatment only produced an atten-
uation of CTA at one dose (2.50 mg/kg). Groups VD2, VD3, 
and VD4 did not differ from each other although each dif-
fered from VDl. Thus, the minimum effective dose of diaze-
pam for producing CTA in this paradigm appears to be be-
tween 0.625 and 1.25 mg/kg. Group DDl (0.625 mg/kg) also 
had a significantly lower SPR than group VV, although group 
YDl (0.625 mg/kg) did not differ from VV. There is no 
statistical basis for concluding that group DDl had a 
lower saccharin preference ratio than group VDl. Such a 
hypothesis is excluded by the use of a one-tailed test, 
and the appearance that the two curves cross in Figure 2 
cannot be statistically validated. In any case, the re-
search hypothesis specifically excludes the possibility 
that a drug pretreated group may have a lower SPR (have a 
stronger aversion) than the corresponding vehicle pre-
treated group. The use of a one-tailed test was based 
upon evidence provided by previous research on the pre-
treatment effect (see Chapter I). 
Group DV (5.0 mg/kg) did not differ from group VV, 
which shows that pretreatment per se did not influence 
the establishment of CTA. Group DV received the highest 
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dose used in this study (5.0 mg/kg) and it is assumed that 
the use of lower doses would not have produced any differ-
ence between group DV and group VV. 
D-Amphetamine 
The paradigm outlined in Table I was slightly modified 
for the second (low doses) experiment with this drug. The 
1.0 mg/kg dose was included in both experiments and neither 
the drug pretreated (DD) nor vehicle pretreated (VD) groups 
differed in saccharin preference ratios between the two ex-
periments. The SPR scores of group vv also did not differ 
between the two experiments. The procedural differences 
between the two experiments did not produce any statisti-
cally reliable difference in preference ratios, although 
Figure 3 suggests the trend may have been for the 1.0 mg/kg 
groups to score somewhat higher in the second (low doses) 
study. 
The pretreatment effect was demonstrated at doses of 
0.25 and 4.0 mg/kg d-amphetamine. CTA training in vehicle 
pretreated subjects produced aversions at doses of 1.0, 
2.0, 4.0, and 8.0 mg/kg as reflected in the difference be-
tween these groups and group VV. These aversions were 
fairly strong (SPR < 0.35), yet pretreatment was only ef-
fective at two doses. At a dose of 4.0 mg/kg, pretreat-
ments attenuated but did not entirely block CTA (group DD3 
of part one had an SPR below group VV but above group VD3). 
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At a dose of 0.25 mg/kg the pretreatments entirely blocked 
CTA formation, but at this dose little aversion could be 
produced to begin with. Although Figure 3 suggests that 
group DDl (0.25 mg/kg) had a higher SPR than group VV, 
the test hypothesis as written forces the conclusion that 
this group did not differ from group VV. 
It would appear unlikely that doses of 0.25 and 4.0 
mg/kg could produce the pretreatment effect when all doses 
in between were ineffective. A more likely alternative is 
that the 0.25 mg/kg dose does not actually produce attenu-
ation of CTA and the results reported here were due to 
chance at this dose. Group DDl (0.25 mg/kg) had one of 
the lowest variances reported in any experiment (as well 
as a low value of n=4) which contributed to the finding 
that CTA was attenuated. 
The shape of the two curves in Figure 3 suggests that 
.the magnitude of the pretreatment effect is independent of 
dose within a certain range. It appears that the degree 
of attenuation may be constant between doses of 0.50 and 
4.0 mg/kg d-amphetamine. No attenuation of CTA occurred 
at a dose of 8.0 mg/kg and probably none would be found 
at doses below 0.25 mg/kg, but further work is needed to 
confirm this point. 
Group DV (1.0 and 8.0 mg/kg) did not differ from 
group VV in either experiment. Thus, pretreatment per se 
did not influence the establishment of CTA. It is assumed 
that the use of other doses for group DV would not have 
produced any difference between this group and group VV, 
since the highest dose (8.0 rng/kg) did not do so. 
Morphine 
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The pretreatment effect was demonstrated only for the 
highest dose (69.1 mg/kg) of morphine. CTA training in 
vehicle pretreated groups produced an aversion at doses 
of 34.6 and 69.1 mg/kg as reflected in the difference be-
tween these groups and group VV. These aversions were 
fairly strong (SPR < 0.30) and the attenuation produced by 
pretreatment was not total (the group pretreated with 69.1 
mg/kg morphine had an SPR higher than the vehicle pre-
treated group but lower than group VV). 
The appearance that the two curves cross in Figure 4 
cannot be statistically validated. The use of a one-
tailed test specifically excludes the possibility that a 
drug pretreated group may have a lower SPR than the cor-
responding vehicle pretreated group. The use of a one-
tailed test was based on evidence provided by previous 
research on the pretreatment effect (see Chapter I). 
Group DV (69.1 mg/kg) did not differ from group VV, 
which shows that pretreatment per se did not influence the 
establishment of CTA. Group DV received the highest dose 
used in this experiment and it is assumed that the use of 
lower doses would not have produced any difference between 
group DV and group VV. 
Demonstration of the Crossover 
Pretreatment Effect 
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The demonstration of a crossover pretreatment effect 
requires that the doses of all UCS drugs employed be 
equally effective in producing CTA. Doses should also be 
chosen which are known to produce attenuation of CTA when 
same-drug pretreatments are given. Ideally, the magnitude 
of attenuation produced by same-drug pretreatments should 
be equivalent for each drug at the doses used. 
No significant differences in saccharin preference 
ratio were detected among the three vehicle pretreated 
groups (Table II). This result indicates that diazepam 
(2.5 mg/kg), amphetamine (4.0 mg/kg), and THC (4.0 mg/kg) 
were equally effective UCS drugs at the doses used. It 
should be noted that each of the pretreated groups had a 
high variance. 
Diazepam pretreatment attenuated CTA produced by di-
azepam, and amphetamine pretreatment attenuated CTA pro-
duced by amphetamine. However, THC pretreatment did not 
attenuate CTA produced by THC. These results replicate 
the findings from the dose-response studies which show that 
a 2.5 mg/kg dose of diazepam and a 4.0 mg/kg dose of am-
phetamine each are capable of attenuating CTA produced by 
the same drug. ~fuen diazepam or amphetamine were the UCS 
drugs the mean SPR of both the vehicle pretreated and drug 
pretreated groups did not differ between the twoexperiments. 
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For these two drugs the degree of attenuation produced by 
pretreatment was the same in both experiments. 
The failure to demonstrate the pretreatment effect 
for THC places a limit on conclusions concerning the ef-
fect of THC pretreatments on CTA induced by diazepam or 
amphetamine. Since THC pretreatments failed to attenuate 
CTA induced by THC it is not surprising that THC pretreat-
ments did not attenuate CTA induced by diazepam or ampheta-
mine. Diazepam pretreatments did attenuate CTA induced by 
THC (group DZP/THC) and it is interesting to note that the 
mean SPR of this group was quite close to the mean for group 
THC/THC. The high variance of group THC/THC was due to only 
one subject (which had an SPR of 0.32, while the other four 
ranged from 0.81 to 0.89) and this effect may well have ob-
scured a pretreatment effect for group THC/THC. 
Groups AMPH/DZP and DZP/THC demonstrated the crossover 
pretreatment effect. Tests for the symmetry of crossover 
are only valid between combinations of diazepam and ampheta-
mine since group'THC/THC did not have an attenuated CTA. 
Pretreatment with diazepam or amphetamine attenuated CTA 
induced by the same compound. Amphetamine pretreatment at-
tenuated CTA induced by diazepam, but diazepam pretreatment 
failed to attenuate CTA induced by amphetamine. 
Conclusions 
Results of the research on CTA present a challenge to 
both the psychologist and pharmacologist. Behaviorists 
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have traditionally regarded all stimuli as neutral, posi-
tively reinforcing, or negatively reinforcing. It has 
been demonstrated that the same drug stimuli that are 
effective in maintaining self-administration are also 
capable of inducing CTA (Cappell & LeBlanc, 1977). This 
indication that the sarrLe dose of a drug may be either pos-
itively or negatively reinforcing receives additional sup-
port from the finding that both behaviors (self-
administration and taste aversion) may occur simultaneously 
(Wise et al., 1976). Conditioned taste aversion also dif-
fers from classical conditioning with respect to the "con-
tiguity rule" of conditioning and the rule of the "equi-
potentiality of conditioned stimuli" and consequently has 
not been well incorporated into general learning theory 
(see Chapter I). 
Some resolution of the apparent paradoxes of CTA is 
obtained by exarnining these phenomena from a viewpoint 
closer than the organismic level. One of the tenets of 
pharmacology is that drugs have multiple actions. Diaze-
pam is used as a minor tranquilizer, a muscle relaxant, 
and an anticonvulsant. The view that a drug must beeither 
positively or negatively reinforcing (or neutral) depends 
upon the assumption that the drug effects act as a single 
stimulus. Cappell and LeBlanc (1973) note that reinforce-
ment schedules and ongoing behavior at the time of condi-
tioning have much influence on the consequences of 
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reinforcers, thus the nature of a drug's reinforcing ac-
tion may be situation-specific. 
Tolerance and/or dependence have often been implicated 
in the pretreatment effect for CTA. Kalant at al. (1971) 
define tolerance as an acquired change due to repeated 
exposure to a drug such that 
• an increased amount of drug is required to 
produce the same specified degree of effect, or 
less effect is produced by the same dose of drug. 
This definition of tolerance is valid only for a 
specified individual drug action, and not neces-
sarily for the composite picture of all actions 
of a given drug on the \.,rhole organism (p. 137). 
Tolerance is further divided into two classes. Dis-
positional tolerance includes changes in a drug's absorp-
tion, distribution, excretion, and metabolism which alter 
its effect upon the target tissue. Functional tolerance 
includes changes in the target tissue which make it less 
sensitive to the drug. The concentration of the drug in 
the blood or brain (rather than the administered dose) is 
needed to differentiate these two classes of tolerance. 
Another common distinction is between physiological and 
psychological (or 11 learned 11 ) tolerance. The former is said 
to involve homeostatic control mechanisms while the latter 
involves the learning of new skills and adaptive behaviors 
to circumvent the effects of a drug. However, Kalent et 
al. (1971, p. 158), in a review of the research on this 
question, conclude that 11 ••• 'learned tolerance' is es-
sentially the same as 'physiological tolerance,' except 
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that it is acquired somewhat more rapidly." They propose 
the term ''behaviorally augmented tolerance" in place of 
''learned tolerance" to emphasize the similarity to physio-
logical tolerance. 
Cross-tolerance between ethanol and barbiturates has 
long been recognized. The metabolism of many compounds, 
including psychoactive agents, barbiturates, other hypnot~s, 
sedatives, tranquilizers, and antihistamines, is known to 
increase rapidly through induction of drug-metabolizing 
systems. More than 200 drugs and environmental agents are 
known to stimulate the activity of drug-metabolizing en-
zymes. In particular, the hepatic microsomal mixed-
function oxidase system has a low order of substrate spe-
cificity and its induction by one drug may increase the 
rate of metabolism of many other drugs (metabolic cross-
tolerance). The fact that drug X can induce the metabolism 
of drug Y does not imply that the converse is true. A 
drug may also be capable of inducing the metabolism of 
other compounds even though it does not induce its own 
metabolism. For example, chlorpromazine induces hepatic 
microsomal metabolism of other drugs and its metabolism 
is induced by phenobarbital pretreatment, yet chlorproma-
zine does not cause significant induction of its own meta-
bolic enzymes (Kalant et al., 1971). 
The results of the experiments reported here indicate 
that the pretreatment effect is operative for certain doses 
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of diazepam (2.5 mg/kg), amphetamine (4.0 mg/kg), and mor-
phine (69.1 mg/kg). In a crossover pretreatment design 
the same two doses of diazepam and amphetamine produced 
equivalent levels of aversion in vehicle pretreated con-
trols and the pretreatment effect was again demonstrated 
at these doses. A crossover pretreatment effect was demon-
strated for subjects pretreated with amphetamine (4.0 mg/ 
kg) and conditioned with diazepam (2.5 mg/kg). However, 
diazepam pretreatment did not attenuate CTA induced by am-
phetamine and therefore symmetry of the crossover pretreat-
ment effect was not demonstrated. The pretreatment effect 
is interpreted in terms of tolerance due to the repeated 
exposures to the drug prior to conditioning. Cross-
tolerance is suggested as a possible explanation for the 
crossover pretreatment effect, with the notation that the 
induction of such tolerance was not symmetrical. These 
hypotheses are offered without reference to the class of 
tolerance involved or the cellular mechanism of tolerance. 
One objection to the tolerance hypothesis is that it 
is difficult to explain the extremely wide range of ef-
fective drugs using this concept. The induction of tol-
erance and cross-tolerance for such a wide range of drugs 
has not been established. Since agonist-antagonist pairs 
are often effective it would be necessary to show that 
more antagonists have agonist activity than has hereto-
fore been demonstrated. 
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Another hypothesis which overcomes the difficulty of 
explaining the wide range of effective drugs is the stress 
hypothesis. According to this hypothesis, certain physio-
logical changes which occur under the influence of drug 
induced stress form the aversive properties common to CTA 
regardless of the specific UCS (Fischer, 1978). The pre-
treatment and crossover pretreatment effects are due to 
adaptation and/or habituation to these as yet unspecified 
physiological changes. The stress hypothesis and the tol-
erance hypothesis need not be mutually exclusive. 
The generality of the stress and tolerance hypotheses 
is both an advantage and a disadvantage. Only a very 
general phenomenon could explain the wide range of effec-
tive UCS drugs and the apparent paradoxes of CTA. But 
models for the fundamental cellular mechanism of tolerance 
or stress are still rudimentary. A few physiological pro-
cesses known as "biochemical correlates" of tolerance have 
been established but whether they are causes or consequen-
ces of tolerance has not been determined (Kalant et al., 
1971). As stated here, the stress and tolerance hypothe-
ses are hardly specific enough to allow for refritation and 
more knowledge of the details of these two phenomena are 
needed. The difficulties encountered with these two hy-
potheses are certainly no greater than those encountered 
with the alternatives. Perhaps Cappell and LeBlanc (197Sa, 
p. 161) were correct in speculating that "Very likely, no 
single hypothesis will be able to embrace all of the data 
in this general area. II 
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APPENDIX 
TABLES III, IV, AND V 
73 
Group Dose 
(rng/kg) 
DD1 0.625 
VD1 0.625 
DD2 1. 25 
VD2 1. 25 
DD3 2.50 
VD3 2.50 
DD4 5.00 
VD4 5.00 
DV 5.00 
vv 0.00 
TABLE III 
GROUP SCORES FOR DIAZEPAM 
DOSE-RESPONSE STUDY 
n Mean Saccharin 
Preference Ratio 
6 0.599 
6 0.728 
6 0.586 
6 0.455 
6 0.754 
6 0.441 
5 0.648· 
6 0.361 
6 ·o.8o2 
6 0.792 
Standard 
Deviation 
0.103 
0.152 
0.292 
0.322 
0.102 
0.352 
0.264 
0.276 
0.101 
0.115 
Group Dose 
(mg/kg) 
DD1 1. 00 
VD1 1. 00 
DD2 2.00 
VD2 2.00 
DD3 4.00 
VD3 4.00 
DD4 8.00 
VD4 8.00 
DV 8.00 
vv 0.00 
TABLE IV 
GROUP SCORES FOR D-AMPHETAMINE 
DOSE-RESPONSE STUDY 
n Mean Saccharin 
Preference Ra.tio 
Part 1·: High Doses 
6 0.601 
6 0.343 
6 0. 418 
6 0.279 
6 0.364 
5 0.068 
4 0.129 
4 0.137 
5 0.717 
6 0.672 
Standard 
Deviation 
0.262 
0.342 
0.248 
0.371 
0.209 
0.113 
0.104 
0.237 
0.251 
0.159 
-....] 
Ln 
TABLE IV (Continued) 
Group Dose n Mean Saccharin Standard 
(mg/kg) Preference Ratio Deviation 
Part 2: Low Doses 
DD1 0.25 4 0.897 0.029 
VD1 0.25 5 0.076 0.218 
DD2 0.50 6 0.740 0~176 
VD2 0.50 6 0.658 0.131 
DD3 0.75 6 0.709 0.100 
VD3 0.75 6 0.633 0.299 
DD4 1.00 6 0.709 0.275 
VD4 1.00 6 0.570 0.303 
DV 1. 00 6 0.799 0.201 
vv 0.00 6 0.776 0.141 
Group Dose 
(mg/kg) 
DD1 3.46 
VD1 3.46 
DD2 6.91 
VD2 6.91 
DD3 34.6 
VD3 34.6 
DD4 69.1 
VD4 69.1 
DV 69.1 
vv 0.00 
TABLE V 
GROUP SCORES FOR HORPHINE 
DOSE-RESPONSE STUDY 
n Mean Saccharin 
Preference Ratio. 
6 0.674 
6 0.781 
6 0.518 
6 0.679 
6 0.438 
6 0.262 
6 0.449 
6 0.250 
6 0.868 
6 0.797 
Standard 
Deviation 
0.276 
0.109 
0.192 
0.350 
0.266 
0.087 
0.212 
0.141 
0.078 
0.094 
-....] 
-....] 
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